Project Grant T32CA315091
- The National Cancer Institute awarded the University of Southern California $162,501 on May 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support methodological training for social and behavioral research in cancer control. The award funds a T32 training program that will provide six predoctoral trainees per year with innovative methodological training focused on social and behavioral cancer control and prevention research. The program applies novel study design,...
- The National Cancer Institute awarded the University of Southern California $135,163 on August 4, 2026, under the Cancer Research Manpower program (CFDA 93.398) for Project Grant K99CA293236, a research effort examining epigenetic barriers to stem cell transformation in colorectal cancer. The funded research investigates how the repressive histone modification H3K27ME3 establishes an epigenetic gatekeeping mechanism that restricts stemness programs to intestinal stem cells and how erosion of...
- The National Cancer Institute awarded $269,597 to the Beckman Research Institute of The City of Hope on August 10, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and deliver clinical trials nursing education. The recipient will create a curriculum to train oncology clinical trials nurses in quality care for patients enrolled in cancer treatment trials, deliver the curriculum through five national in-person courses and virtual offerings to competitively selected...
- The National Cancer Institute awarded the University of Southern California $699,303 on August 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to identify pre-diagnostic epigenetic biomarkers of colorectal cancer risk and understand epigenetic mechanisms of lifestyle and genetic CRC risk factors across multiple U.S. populations. The research will conduct a nested case-control study of 1,500 colorectal cancer cases and 1,500 matched controls drawn from the...
- The National Cancer Institute awarded The Regents of the University of California, San Francisco $132,618 on December 1, 2025, under the Cancer Research Manpower program (CFDA 93.398) to support mentored training for a PhD student in epidemiology at UCSF to become a researcher in cancer health disparities. The award funds a Ruth L. Kirschstein National Research Service Award (F31) that provides the trainee with expertise in translational research, geospatial data analysis, and causal inference...
- The National Cancer Institute awarded the Beckman Research Institute of the City of Hope $162,000 on August 11, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and pilot a self-directed e-learning delivery model for clinical cancer genomics education. The recipient will convert selected core recorded didactic modules from its established Intensive Course in Clinical Cancer Genomics into a self-directed e-learning course bundle using theoretically grounded...
- The National Cancer Institute, part of the National Institutes of Health under the Department of Health and Human Services, awarded Duke University $302,524 on September 10, 2025, under the Cancer Research Manpower program (CFDA 93.398). The award funds a postdoctoral research fellowship (F32) to investigate the role of SMARCAL1, an annealing helicase, in promoting glioma cell proliferation and suppressing tumor-intrinsic inflammation in alternative lengthening of telomeres (ALT)–positive...
- The National Cancer Institute awarded Dana-Farber Cancer Institute, Inc. $170,394 on July 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support postdoctoral research training in cancer epigenetics. The award funds research examining polycomb repressive complexes and chromatin remodeling in neuroendocrine lineage carcinomas, particularly the transformation of conventional prostate adenocarcinoma into small-cell neuroendocrine prostate cancer. The investigator will conduct...
- The National Cancer Institute awarded the University of North Carolina at Chapel Hill $536,807 on September 1, 2026, for continued support of the Cancer Health Drivers Training Program (CHDP), a postdoctoral training initiative under the Cancer Research Manpower program (CFDA 93.398). The CHDP trains postdoctoral fellows with backgrounds in epidemiology, behavioral science, medicine, and related disciplines to conduct research on drivers of and interventions to reduce cancer-related health...
- The National Cancer Institute awarded The Leland Stanford Junior University $166,968 on August 15, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop single-molecule multi-omics sequencing methods for spatially resolved epigenetic profiling of extrachromosomal DNA (ecDNA) molecules and to investigate the relationship between ecDNA spatial organization, epigenetic landscape, and transcriptional regulation. The work addresses a technical gap in understanding ecDNA's...
The National Cancer Institute awarded the University of Southern California $254,091 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support postdoctoral training in integrative cancer epidemiology. The award funds a joint training program administered by USC's Norris Comprehensive Cancer Center and the University of Hawaii Cancer Center. The program trains postdoctoral fellows for independent careers in integrative cancer epidemiology research, emphasizing applied experience across nutritional, environmental, molecular, genetic, and translational epidemiology. Training capitalizes on USC's expertise in genetic, environmental, biomarker, biostatistics, and data science programs and the University of Hawaii's strengths in nutritional, lifestyle, behavioral, and molecular risk factors. The program investigates behavioral, lifestyle, cultural, environmental, genetic, and omic risk factors across populations experiencing striking differences in cancer incidence and mortality. Over the preceding five years, six of nineteen supported postdocs advanced to faculty positions and three to research positions at non-academic institutions; trainees authored 118 peer-reviewed publications and 50 scientific presentations and secured two K99/R00 awards, one R01, and three additional grants. Work is performed in Los Angeles, California. The period of performance runs from September 1, 2026, through August 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $254.1k | 7/20/26 |